New female contraceptive under development: end-user preferences revealed in web-based survey

FHS
July 26, 2023
9:01 am

Researchers investigated prospective end-user preferences for an on-demand, non-hormonal female contraception.

AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine

People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or

October 24, 2023

Softball: Lyons’ star pitcher and catcher leaning on over a decade of camaraderie – The Cannabist

Lyons High School may be small, but the level of talent it possesses on the softball field has the Lions swinging like a heavyweight. The

September 19, 2024

Novo Nordisk enters deal to develop therapies for obesity

The companies will partner to develop multitarget therapies that act on the GLP-1 receptor. Credit: Hunterframe / Shutterstock.com. Novo Nordisk has entered a research partnership

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.